Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS Studies - Sorbonne Université Access content directly
Conference Papers Year : 2018

Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS Studies

Andres Gelrud
  • Function : Author
Andres Digenio
  • Function : Author
Veronica Alexander
  • Function : Author
Karren Williams
  • Function : Author
Ionna Gouni-Berthold
  • Function : Author
Erik Stroes
  • Function : Author
Richard Geary
  • Function : Author
Steven Hughes
  • Function : Author
Sotirios Tsimikas
  • Function : Author
Daniel Gaudet
  • Function : Author
No file

Dates and versions

hal-03969825 , version 1 (02-02-2023)

Identifiers

Cite

Andres Gelrud, Andres Digenio, Veronica Alexander, Karren Williams, Ionna Gouni-Berthold, et al.. Treatment with Volanesorsen (VLN) Reduced Triglycerides and Pancreatitis in Patients with FCS and sHTG vs Placebo: Results of the APPROACH and COMPASS Studies. International Symposium on Atherosclerosis (ISA), Jun 2019, Toronto, Canada. pp.157, ⟨10.1016/j.atherosclerosissup.2018.04.476⟩. ⟨hal-03969825⟩
8 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More